Exclusive Relationship. USER shall not offer or sell a product or service with the same or similar services as those provided within the COMPANY Program with another entity other than COMPANY in its offices where the COMPANY Product is provided pursuant to this Agreement.
Exclusive Relationship. The parties acknowledge and agree that Impax will obtain access to Confidential Information of Medicis with respect to the Original Products and any development work relating to the New Product, all of which may provide Impax with a competitive advantage. Accordingly, during the term of this Agreement and for XXXXX thereafter (unless this Agreement is terminated on account of Medicis’ uncured material breach of its payment obligations under this Agreement), Impax shall not, and nor shall Impax directly or indirectly encourage or assist any Third Party to, develop and/or commercialize any product that contains XXXXX; provided, however, that such restriction shall not apply to XXXXX.
Exclusive Relationship. Subject to Section 3.2, neither Kallikrein LLC, Genzyme, Dyax nor any of their respective Affiliates shall independently, or with a Third Party, conduct research or development activities regarding, or engage in the manufacture, marketing, sale or distribution of, DX-88 and any other protein/peptide product that inhibits the activity of human plasma kallikrein during the term of this Agreement other than as part of the Program. In addition, during the two-year period following termination of this Agreement, neither (a) the breaching Party and its Affiliates in the case of termination pursuant to Section 13.2.1 hereof, (b) the terminating Party and its Affiliates in the case of termination pursuant to Section 13.2.2 hereof, (c) the non-terminating Party and its Affiliates in the case of termination pursuant to Sections 13.2.3 and 13.2.4 hereof nor (d) Genzyme in the case of termination pursuant to Section 13.2.5 hereof shall independently, or with a Third Party, conduct research regarding, or engage in the manufacture, marketing, sale or distribution of, protein/peptide products that inhibit the activity of human plasma kallikrein; PROVIDED, HOWEVER, that in the event that this Agreement is terminated pursuant to Sections 13.2.2 or 13.2.5 hereof and the non-terminating Party, or Dyax in the case of termination pursuant to Section 13.2.5 hereof, does not exercise its option under Sections 13.3.2(a) or 13.3.5(a) hereof, then the restrictions set forth in this sentence shall not apply. Notwithstanding the foregoing, nothing herein is intended to restrict Genzyme, Dyax or their respective Affiliates from conducting research or development activities regarding, or engaging in the manufacture, marketing, sale or distribution of, "small molecule" drugs (as defined in Section 1.3).
Exclusive Relationship. Except for the three (3) "
Exclusive Relationship. 9.1 During the term of this Agreement the parties shall work exclusively with one another for Compound delivery by MTS.
Exclusive Relationship. The Franchisor is entering into this Agreement with the Marketer on the condition that the Marketer will deal exclusively with the Franchisor. The Marketer acknowledges and agrees that the Franchisor would be unable to protect its Confidential Information and would be unable to encourage a free exchange of ideas and information among area marketers and the Franchisor if area marketers were permitted to hold interests in any Competitive Business, as defined below. The Marketer therefore agrees that, during the term hereof, neither the Marketer, the Marketer's officers, directors, shareholders, members, managers, partners and equivalents who participate in the management of the Marketer, nor the Marketer's spouse, and, if applicable, the Principal Owner, shall:
Exclusive Relationship. 8 2.05.01 SIGNAL .................................................. 8 2.05.02
Exclusive Relationship. During the term of this Agreement, Fiscal Sponsor will serve as the exclusive fiscal sponsor for the Project, meaning no other entity may hold assets or incur liabilities on behalf of the Project, engage in Project activity, or represent the Project as its own program.
Exclusive Relationship. Except as provided by Section 3.5 below, neither Party nor any of their Affiliates shall independently, or with a Third Party, conduct research or development activities or grant a license or sublicense regarding, or engage in the manufacture, marketing, sale or distribution in the Territory of Collaboration Products in the Field during the term of the Program other than as part of the Program. In addition, during the [***] following termination of the Program, neither (a) the breaching Party and its Affiliates in the case of termination pursuant to Section 13.2.1 hereof, (b) the terminating Party and its Affiliates in the case of termination pursuant to Section 13.2.2 hereof and (c) the non-terminating Party and its Affiliates in the case of termination pursuant to Section 13.2.3 hereof shall independently, or with a Third Party, conduct research regarding, or engage in the manufacture, marketing, sale or distribution in the Territory of, Collaboration Products in the Field; provided, however, that in the event that this Agreement is terminated pursuant to Section 13.2.2 hereof and the non-terminating Party does not exercise its option under Section 13.3.2 hereof, then the restrictions set forth in this sentence shall not apply.
Exclusive Relationship. During the term of this Agreement, neither RenaGel LLC, GelTex nor Genzyme, nor any of their respective Affiliates shall independently, or with a Third Party, conduct research regarding, or engage in the manufacture, marketing, sale or distribution of, products in the Field and in the Territory other than as part of the Program. In addition, during the two-year period following termination of this Agreement, neither (a) the breaching Party or its Affiliates in the case of termination pursuant to Section 13.2.1 hereof, (b) Genzyme or its Affiliates in the case of termination pursuant to Section 13.2.2 hereof, (c) the terminating Party and its Affiliates in the case of termination pursuant to Section 13.2.3 hereof or (d) the non-terminating Party and its Affiliates in the case of termination pursuant to Sections 13.2.4 and 13.2.5 hereof shall independently, or with a Third Party, conduct research regarding, or engage in the manufacture, marketing, sale or distribution of, products in the Field in the Territory; provided, however, that in the event that this Agreement is terminated pursuant to Section 13.2.3 and the non-terminating Party does not exercise its option under Section 13.3.3(a), then the restrictions set forth in this sentence shall not apply.
